Biomea Fusion, Inc. (“Biomea”) (nasdaq: bmea), a clinical-stage diabetes and obesity company, announced today that it has commended an underwritten public offering of shares of being common stock and accompanyinging to purcha themes of its) and esoge in larrants in lares and its in larrants in liares in liabites in liares in liares in liares […]
